top
Search terms
Results 1 - 10 of 54 - ordered by :
Pages: 1 2 3 4 5 6 ... 6
Ehjcardioimaging

[...]cardiovascular events largely occur in the low-to-intermediate risk class part of the adult population in which preventive measures are inevitably less aggressively recommended.1 Accordingly, we ...

European Heart Journal - Cardiovascular Imaging, EDITORIALS, Pompilio Faggiano, Nicola Gaibazzi

Date : 01/06/2015
Ehjournal

Abstract Aims To compare the efficacy [low-density lipoprotein cholesterol (LDL-C) lowering] and safety of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin 9, ...

European Heart Journal, Coronary artery disease, Christopher P. Cannon, Bertrand Cariou, Dirk Blom, James M. McKenney, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

Date : 14/05/2015
Ehjcardiovascrec

Collectively, nine potentially modifiable risk factors (smoking, hypertension, diabetes, waist/hip ratio, dietary patterns, physical activity, consumption of alcohol, plasma apolipoproteins, and ...

Cardiovascular Research, Review, Viola Vaccarino, Lina Badimon, Roberto Corti, Cor de Wit, Maria Dorobantu, Alistair Hall, Akos Koller, Mario Marzilli, Axel Pries, Raffaele Bugiardini

Date : 01/04/2011
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 08/03/2017 Item size : 424498 bytes
Ehjournal

Initially thought to have their effect by reducing the size of atherosclerotic plaque, increasing evidence shows a far greater effect on endothelial function and plaque composition, including less ...

European Heart Journal, Kinlay, Scott

Date : 01/07/2008 Item size : 151575 bytes
Ehjournal

B-mode ultrasound measurement of the carotid intima media thickness (cIMT) is the best validated imaging modality and most widely used surrogate endpoint in intervention studies to evaluate treatment ...

European Heart Journal, van der Valk, Fleurtje M., van Wijk, Diederik F., Stroes, Erik S. G.

Date : 01/12/2012 Item size : 148551 bytes
Ehjournal

Methods and results We performed a 10-year follow-up analysis in 812 coronary artery disease (CAD) patients (REGRESS cohort), treated with statins after an initial 2-year study period. The formation ...

European Heart Journal, Regieli, Jakub J., Jukema, J. Wouter, Grobbee, Diederick E., Kastelein, John J.P., Kuivenhoven, Jan Albert, Zwinderman, Aeilko H., van der Graaf, Yolanda, Bots, Michiel L., ...

Date : 01/11/2008
Ehjournal

Patients receiving statin therapy ( \(n=269\) , 52%) had a lower level of inflammation (hs-CRP \(p{<}0.001\) , SAA \(p=0.001\) , fibrinogen \(p=0.007\) , albumin \(p{<}0.001\) , neutrophils ...

European Heart Journal, Schillinger, Martin, Exner, Markus, Mlekusch, Wolfgang, Amighi, Jasmin, Sabeti, Schila, Muellner, Marcus, Rumpold, Helmut, Wagner, Oswald, Minar, Erich

Date : 01/05/2004
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 09/03/2017
Ehjournal

Abstract Aims To compare the efficacy [low-density lipoprotein cholesterol (LDL-C) lowering] and safety of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin 9, ...

European Heart Journal, Cannon, Christopher P., Cariou, Bertrand, Blom, Dirk, McKenney, James M., Lorenzato, Christelle, Pordy, Robert, Chaudhari, Umesh, Colhoun, Helen M.

Date : 14/05/2015 Item size : 271307 bytes